August 9, 2019
Calendar of Events
Sept. 29-Oct. 1
Sr. Management Conference
Half Moon Bay, CA
November 7
Breakfast at AMP 2019
Baltimore, MD

November 12
Service & Support Executives Meeting
Boston, MA
December 3 
Dinner for Senior Executives
Boston, MA

January 28
Breakfast at SLAS 2020
San Diego, CA
March 10
Marketing & Sales Executives Meeting
Boston, MA
April 1
Breakfast at Analytica 
Munich, Germany

May 3-5
Spring Senior Executives Meeting
Boston, MA

October 4-6
Senior Management Conference
Laguna Beach, CA
Helix Joins ALDA

Helix, a San Francisco-based genomics company funded by several sources including Illumina, is the latest company to join ALDA.  The companyis accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay, Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery.
Marc Stapley, Chief Executive Officer and formerly a senior executive at Illumina and a former member of the ALDA Board of Directors, will be the Official Representative to ALDA. Justin Kao, Co-founder and Senior Vice President, Business Development & Partnerships, will be the Alternate Representative.
For more information about Helix and their products and services, please consult their web site at
AACC Breakfast Discusses Strategies, Challenges and Needs for Clinical Diagnostic Labs 
ALDA held a breakfast meeting earlier this week during the AACC Conference in Anaheim, California. More than 50 senior executives attended the event and heard a well –received talk from our guest speaker Dr. Sandra Gunselman, Executive Director of the Advanced Diagnostics Laboratories at the National Jewish Health.  
Dr. Gunselman shared her perspective on strategies, challenges and needs for clinical diagnostic laboratories developing and offering lab developed tests. 
Some of the challenges discussed included: 
  • Continual inspection readiness as they experience tougher and constant audits
  • Cybersecurity and General Data Protection Regulations (GDPR) 
  • Data and analytics are not standardized for regulatory compliance
  • Expensive and numerous interfaces with clients
  • Quest and LabCorp are now in-network which is forcing the need to partner
  • The Protecting Access to Medicare Act (PAMA) of 2014
  • Decline in amount reimbursed under Medicare Part B: 45% in 2019 reimbursement → 28% in 2020
  • FDA Oversight Threat is constant
The two needs Dr. Gunselman shared included: 
  1.  A whole blood test system to evaluate immunologic responses, and 
  2. Population-Based Medicine to rank the importance of problems, the employment of cost effectiveness, the analyses of different interventions, and the promotion of sound managerial techniques to implement the programs.   
If you’d like to review Dr. Gunselman’s presentation, please contact Carol Starke at
Executives Breakfast at AACC Annual Meeting 2019


Make Your Fall Conference Hotel Reservations 

For hotel reservations, please call The Ritz-Carlton Half Moon Bay at (650) 712-7000 or (800) 241-3333 and reference “ALDA Sr. Management Conference” or “Analytical, Life Science & Diagnostics Association”.  You can also make reservations using the RCHMB Passkey web site: ttps://book.
or Passkey reservation line: (888) 293-0524.

LinkedIn LinkedIn
Twitter Twitter
Website Website
Fall Conference to Focus on Immunology and How It Will Advance Medicine 
Register now to attend Sept. 29-October 1 Meeting
Fred Hutch’s Cameron J. Turtle Joins Program

“Immunology: How It Will Advance Medicine and Challenge Members of ALDA” will be the theme of this year’s ALDA Fall Senior Management Conference.  
One of ALDA’s semi-annual meetings directed to presidents, CEOs, COOs and senior executives, the Conference will be held on September 29-October 1 in Half Moon Bay, California.
The rapid advancement of immunology in recent years has significant implications for therapeutics, discovery, translational biology, personalized medicine and cell therapy. Life science companies will be challenged to develop new and innovative analytical tools and technologies. Immunology also will present new demands to ALDA members for diagnostics and for tools used in bioprocessing applications

Presentations at the Fall Conference will include a vision of the future of immunology, and an examination of techniques for studying the immune system, what’s happening in immuno-oncology, and the challenges and bioprosessing
opportunities associated with manufacturing immune cell therapies.
The meeting will feature several well-known speakers on immunology:
  • Matt Richtel, a Pulitzer Prize-winning journalist with the New York Times and author of “An Elegant Defense: The Extraordinary New Science of the Immune System: A Tale in Four Lives.” 
  • Alex Marson, M.D., Ph.D., an Associate Professor at the Univ. of California, San Francisco and Scientific Director of Biomedicine at the Innovative Genomics Institute; and 
  • Lisa H. Butterfield, Ph.D., Vice President of the Parker Institute for Cancer Immunotherapy Research Center and a former President of the Society for Immunotherapy of Cancer.
  • Cameron J. Turtle, Ph.D., Associate Member, Clinical Research Division, and Anderson Family Endowed Chair for Immunotherapy, Fred Hutchinson Cancer Research Center. 
We will have two keynote presentations. On Monday morning, Robert Kaplan, a widely-respected author of 18 books on foreign affairs, will assess the current tariff and trade dispute between the United States and China, and share his insights on how it’s likely to conclude and influence the longer-term trading relationship.
On Tuesday morning, Leon Panetta, one of the US’ most respected and bipartisan political leaders who has served as Secretary of Defense, CIA Director, Budget Director, and White House Chief of Staff, as well as a long-time US Representative from CA, will join us for a conversation on the domestic and global political/economic landscape.
Look for more program details and registration information in your e-mail inbox or contact
Meet Our Fall Conference Speakers: Lisa Butterfield and Alex Marson 

Dr. Lisa H. Butterfield, Ph.D.

Dr. Lisa H. Butterfield of the Parker Institute for Cancer Immunotherapy (“PICI”) Research Center will speak on what’s happening in immune-oncology and present a vision of the future in a presentation entitled, “Harnessing the Immune System to Fight Cancer.” 
Dr. Butterfield is the Vice President of the PICI Research Center, and an Adjunct Professor of Microbiology and Immunology at the University of California, San Francisco. Her primary focus is on cancer vaccines and cellular therapies.
Prior to joining PICI, Dr. Butterfield was a Professor of Medicine, Surgery, Immunology and Clinical and Translational Science at the University of Pittsburgh and Director of the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory. Lisa is a former President of the Society of Immunotherapy of Cancer and currently serves on the Society’s Executive Committee. 
Dr. Butterfield received her Ph.D. in Biology from UCLA, followed by postdoctoral fellowships in Cellular Immunology and Cancer Gene Therapy also at UCLA. She has published over 150 peer-reviewed manuscripts, reviews and book chapters, and mentored over 20 students and postdocs.

Alex Marson, M.D., Ph.D.

Dr. Alex Marson will present a high-level view of his lab’s research and examine techniques used in immunology research using he kinds of products and services our industry supplies.
Dr. Marson is a biologist, specializing in genetics, human immunology, and CRISPR genome engineering. He is a tenured Associate Professor of Microbiology and Immunology at the University of California, San Francisco, where he leads research at the Marson Lab. Alex also currently holds affiliations with the Parker Institute for Cancer Immunotherapy (PICI), the Chan Zuckerberg Biohub and the Innovative Genomics Institute (IGI).
Alex received his A.B. in biology summa cum laude from Harvard University, a master’s degree in Biological Sciences from the University of Cambridge, and a Ph.D. in Biology from MIT. He received his M.D. from Harvard Medical School. 
Dr. Marson's research focuses on reprogramming human immune cells, especially T cells, with CRISPR. The applications of this research are in the treatment of cancer, autoimmune diseases, HIV and a wide-range of other diseases.
We Launched Our New Website with Online Registration


We’re excited to launch our new website!

As with any new site, we understand that there may be glitches, and we apologize for the numerous, unnecessary emails yesterday! Everything is online today, and the meeting registration section is working properly. Of course, we would welcome your feedback as you navigate the site.

The biggest addition is that the site has a ‘Members’ section with an all new online meetings registration and payment function. In addition, there is a public section with our meetings calendar and other prospective member information. If you are an official or alternate representative you should have received an email yesterday with your login credentials to access the ‘Members’ section. Once you get into the ‘Members’ site you will find:

1.  The latest association news,
2. The new online registration and payment capability comes with rapid confirmation of your meeting registration and a payment receipt
3.  Easy access to speaker presentations and attendee lists from past meetings, and
4.  A Member Directory with up to date contact information for key ALDA member executives.

On the new site official and alternate representatives will also be able to add additional executives to our mailing lists. Log in to the ‘Members’ section and go to ‘Member Orientation’ then follow the prompts.

Carol Starke will manage the meeting registrations and the ALDA database which feeds the website so if you have any questions, changes (deletions, new titles), etc. please contact her directly at

For member company executives who are not official and alternate representatives, we expect to roll out your access to the Members Only section shortly. If you need something prior to that please contact Carol.
Copyright © 2019 Analytical, Life Science & Diagnostics Association (ALDA), All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp